MiR-629-5p Promotes Prostate Cancer Development and Metastasis by Targeting AKAP13.

导出 LinkOut

翻译打印收藏纠错

作者： Yangzhou,Liu ^[1] ; Shankun,Zhao ^[2] ; Jiamin,Wang ^[1] ; Zhiguo,Zhu ^[3] ; Lianmin,Luo ^[1] ; Qian,Xiang ^[1] ; Mingda,Zhou ^[1] ; Yuxiang,Ma ^[1] ; Zuomin,Wang ^[1] ; Zhigang,Zhao ^[1]

作者单位： Department of Urology & Andrology, Minimally Invasive Surgery Center, Guangdong Provincial Key Laboratory of Urology, The First Affiliated Hospital of GuangZhou Medical University, Guangzhou, China. ^[1] Department of Urology, Taizhou Central Hospital (Taizhou University Hospital), Taizhou, China. ^[2] Department of Urology, Affiliated Hospital of Jining Medical University, Jining, China. ^[3]

关键词 AKAP13 miR-629-5p phenotype prognosis prostate cancer

DOI 10.3389/fonc.2021.754353

PMID 34722307

发布时间 2021-11-02

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in oncology

2021年11卷

754353页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

MiR-629-5p Promotes Prostate Cancer Development and Metastasis by Targeting AKAP13.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

MiR-629-5p Promotes Prostate Cancer Development and Metastasis by Targeting AKAP13.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

检索历史清除